Engaging a community to focus on upper limb function in people with multiple sclerosis: the ThinkHand campaign case study.

Clinical trials Co-creation Design Multiple Sclerosis Patient public involvement Patient-centred Public engagement

Journal

Research involvement and engagement
ISSN: 2056-7529
Titre abrégé: Res Involv Engagem
Pays: England
ID NLM: 101708164

Informations de publication

Date de publication:
18 Jun 2024
Historique:
received: 16 11 2023
accepted: 18 05 2024
medline: 18 6 2024
pubmed: 18 6 2024
entrez: 17 6 2024
Statut: epublish

Résumé

Solving complex research challenges requires innovative thinking and alternative approaches to traditional methods. One such example is the problem of arm and hand, or upper limb function in multiple sclerosis (MS), a neurological condition affecting approximately 2.9 million people worldwide and more than 150,000 in the United Kingdom. Historically, clinical trials and research have focused on mobility and walking ability. This excludes a large number of patients who are wheelchair users, limiting their quality of life and restricting access to possibly helpful medications. To address this issue, the ThinkHand campaign was launched in 2016, aiming to raise awareness about the importance of upper limb function in MS and develop alternative ways to measure, record, and account for hand and arm function changes. The campaign utilised innovative strategies at scientific conferences and online surveys to engage people affected by MS, healthcare professionals, charities, and researchers in discussing the importance of preserving upper limb function. Through co-design and interdisciplinary collaboration, the campaign developed new tools like the low-cost cardboard version of the Nine-Hole Peg Test, facilitating remote monitoring of hand function. Additionally, the campaign co-created the "Under & Over" rehabilitation tool, allowing individuals with advanced MS to participate in a remote rehabilitation program.The impact of the ThinkHand campaign has been significant, helping to shift the focus of both academic and industry-supported trials, including the O'HAND and ChariotMS trials, both using upper limb function as their primary end point. The campaign's patient-centred approach highlighted the importance of recognising patients' perspectives in research and challenged established assumptions and practices. It demonstrated the effectiveness of interdisciplinary collaboration, systems thinking, and co-creation with stakeholders in tackling complex problems. The ThinkHand campaign provides valuable insights for health research practices. By involving patients at all stages, researchers can gain a deeper understanding of the impact of disease on their lives, identify gaps and focus research on their needs. Experimentation and iteration can lead to innovative solutions, and openness to unconventional methods can drive widespread change. The ThinkHand campaign exemplifies the potential of patient-centred approaches to address complex research challenges and revolutionise the field of MS research and management. Embracing such approaches will contribute to more inclusive and impactful research in the future. Solving complex research challenges requires creative thinking and new ways of doing things. One such challenge is understanding the problems with arm and hand function in multiple sclerosis (MS), a neurological condition that affects more than 150,000 in the United Kingdom. In the past, research focused mainly on walking ability, leaving out many people who use wheelchairs.To tackle this issue, we created the ThinkHand campaign in 2016. Its goal was to raise awareness about the importance of hand and arm function for people with MS (pwMS) and find better ways to measure changes in these functions such that they can become outcomes in clinical trials. This could provide a pathway to better treatments for pwMS who cannot walk.The campaign used various methods, including surveys, social media posts, exhibitions and music to involve pwMS, healthcare professionals, charities, and researchers in discussions about the issues. Working together, they created tools to support pwMS, particularly those at an advanced stage of the disease (pwAMS), to take part in research and measure their hand and arm function. Through our collaborative approach focusing on patients’ perspectives, the campaign challenged old ideas and deeply embedded practices. It showed that collaboration between different areas of expertise involving pwMS at all stages of research can help solve complex problems. This campaign teaches us valuable lessons for health research. When researchers listen to patients and try new things, they can better understand how a disease affects people’s lives and develop better solutions.In conclusion, we show how embracing a patient-centred approach can address complex research challenges and improve how we study and manage MS and other conditions in the future.

Sections du résumé

BACKGROUND BACKGROUND
Solving complex research challenges requires innovative thinking and alternative approaches to traditional methods. One such example is the problem of arm and hand, or upper limb function in multiple sclerosis (MS), a neurological condition affecting approximately 2.9 million people worldwide and more than 150,000 in the United Kingdom. Historically, clinical trials and research have focused on mobility and walking ability. This excludes a large number of patients who are wheelchair users, limiting their quality of life and restricting access to possibly helpful medications. To address this issue, the ThinkHand campaign was launched in 2016, aiming to raise awareness about the importance of upper limb function in MS and develop alternative ways to measure, record, and account for hand and arm function changes.
MAIN BODY METHODS
The campaign utilised innovative strategies at scientific conferences and online surveys to engage people affected by MS, healthcare professionals, charities, and researchers in discussing the importance of preserving upper limb function. Through co-design and interdisciplinary collaboration, the campaign developed new tools like the low-cost cardboard version of the Nine-Hole Peg Test, facilitating remote monitoring of hand function. Additionally, the campaign co-created the "Under & Over" rehabilitation tool, allowing individuals with advanced MS to participate in a remote rehabilitation program.The impact of the ThinkHand campaign has been significant, helping to shift the focus of both academic and industry-supported trials, including the O'HAND and ChariotMS trials, both using upper limb function as their primary end point. The campaign's patient-centred approach highlighted the importance of recognising patients' perspectives in research and challenged established assumptions and practices. It demonstrated the effectiveness of interdisciplinary collaboration, systems thinking, and co-creation with stakeholders in tackling complex problems.
CONCLUSION CONCLUSIONS
The ThinkHand campaign provides valuable insights for health research practices. By involving patients at all stages, researchers can gain a deeper understanding of the impact of disease on their lives, identify gaps and focus research on their needs. Experimentation and iteration can lead to innovative solutions, and openness to unconventional methods can drive widespread change. The ThinkHand campaign exemplifies the potential of patient-centred approaches to address complex research challenges and revolutionise the field of MS research and management. Embracing such approaches will contribute to more inclusive and impactful research in the future.
Solving complex research challenges requires creative thinking and new ways of doing things. One such challenge is understanding the problems with arm and hand function in multiple sclerosis (MS), a neurological condition that affects more than 150,000 in the United Kingdom. In the past, research focused mainly on walking ability, leaving out many people who use wheelchairs.To tackle this issue, we created the ThinkHand campaign in 2016. Its goal was to raise awareness about the importance of hand and arm function for people with MS (pwMS) and find better ways to measure changes in these functions such that they can become outcomes in clinical trials. This could provide a pathway to better treatments for pwMS who cannot walk.The campaign used various methods, including surveys, social media posts, exhibitions and music to involve pwMS, healthcare professionals, charities, and researchers in discussions about the issues. Working together, they created tools to support pwMS, particularly those at an advanced stage of the disease (pwAMS), to take part in research and measure their hand and arm function. Through our collaborative approach focusing on patients’ perspectives, the campaign challenged old ideas and deeply embedded practices. It showed that collaboration between different areas of expertise involving pwMS at all stages of research can help solve complex problems. This campaign teaches us valuable lessons for health research. When researchers listen to patients and try new things, they can better understand how a disease affects people’s lives and develop better solutions.In conclusion, we show how embracing a patient-centred approach can address complex research challenges and improve how we study and manage MS and other conditions in the future.

Autres résumés

Type: plain-language-summary (eng)
Solving complex research challenges requires creative thinking and new ways of doing things. One such challenge is understanding the problems with arm and hand function in multiple sclerosis (MS), a neurological condition that affects more than 150,000 in the United Kingdom. In the past, research focused mainly on walking ability, leaving out many people who use wheelchairs.To tackle this issue, we created the ThinkHand campaign in 2016. Its goal was to raise awareness about the importance of hand and arm function for people with MS (pwMS) and find better ways to measure changes in these functions such that they can become outcomes in clinical trials. This could provide a pathway to better treatments for pwMS who cannot walk.The campaign used various methods, including surveys, social media posts, exhibitions and music to involve pwMS, healthcare professionals, charities, and researchers in discussions about the issues. Working together, they created tools to support pwMS, particularly those at an advanced stage of the disease (pwAMS), to take part in research and measure their hand and arm function. Through our collaborative approach focusing on patients’ perspectives, the campaign challenged old ideas and deeply embedded practices. It showed that collaboration between different areas of expertise involving pwMS at all stages of research can help solve complex problems. This campaign teaches us valuable lessons for health research. When researchers listen to patients and try new things, they can better understand how a disease affects people’s lives and develop better solutions.In conclusion, we show how embracing a patient-centred approach can address complex research challenges and improve how we study and manage MS and other conditions in the future.

Identifiants

pubmed: 38886857
doi: 10.1186/s40900-024-00586-y
pii: 10.1186/s40900-024-00586-y
doi:

Types de publication

Letter

Langues

eng

Pagination

62

Subventions

Organisme : Roche
ID : NCT04035005
Organisme : Morris-Saady Charitable Trust
ID : NCT04695080
Organisme : National Institute of Health and Care Research
ID : 17/145/09

Informations de copyright

© 2024. The Author(s).

Références

Neurology. 1997 Nov;49(5):1419-24
pubmed: 9371932
Mult Scler. 2020 Apr;26(5):548-553
pubmed: 31965877
Pract Neurol. 2017 Jun;17(3):224-228
pubmed: 28404618
Mult Scler. 2017 Dec;23(14):1956-1957
pubmed: 28669257
Mult Scler Relat Disord. 2017 Feb;12:70-78
pubmed: 28283111
Neurology. 1983 Nov;33(11):1444-52
pubmed: 6685237
Mult Scler Relat Disord. 2024 May;85:105529
pubmed: 38447394
Mult Scler Relat Disord. 2019 May;30:1-8
pubmed: 30710887
Mult Scler Relat Disord. 2023 Jan;69:104424
pubmed: 36473240
Mult Scler Relat Disord. 2014 Jan;3(1):31-3
pubmed: 25877970
BMC Health Serv Res. 2015 Apr 23;15:105
pubmed: 25903748
Ther Adv Neurol Disord. 2021 Nov 25;14:17562864211057661
pubmed: 35173808
Mult Scler Relat Disord. 2015 Mar;4(2):95-103
pubmed: 25787185
Am J Occup Ther. 2003 Sep-Oct;57(5):570-3
pubmed: 14527120
Mult Scler Relat Disord. 2017 Oct;17:172-176
pubmed: 29055452
Mult Scler Relat Disord. 2019 Jan;27:247-253
pubmed: 30419510
Brain. 2010 Jul;133(Pt 7):1900-13
pubmed: 20423930
Mult Scler Relat Disord. 2021 Sep;54:103125
pubmed: 34246018
Mult Scler. 2020 Dec;26(14):1816-1821
pubmed: 33174475

Auteurs

Alison Thomson (A)

Centre for Preventive Neurology, Wolfson Institute of Population Health, Queen Mary University of London, London, UK. a.thomson@qmul.ac.uk.

Rachel Horne (R)

Patient Author, Barts MS Advisory Group, Queen Mary University of London, London, UK.

Christine Chapman (C)

Patient Author, Barts MS Advisory Group, Queen Mary University of London, London, UK.

Trishna Bharadia (T)

Patient Author, Barts MS Advisory Group, Queen Mary University of London, London, UK.

Patrick Burke (P)

Patient Author, Barts MS Advisory Group, Queen Mary University of London, London, UK.

Elizabeth Colwell (E)

Patient Author, Barts MS Advisory Group, Queen Mary University of London, London, UK.

Mark Harrington (M)

Patient Author, Barts MS Advisory Group, Queen Mary University of London, London, UK.

Bonnie Boskovic (B)

Patient Author, Barts MS Advisory Group, Queen Mary University of London, London, UK.

Andrea Stennett (A)

Centre for Preventive Neurology, Wolfson Institute of Population Health, Queen Mary University of London, London, UK.
Clinical Board Medicine (Neuroscience), Barts Health NHS Trust, The Royal London Hospital, London, UK.

David Baker (D)

The Blizard Institute, Centre for Neuroscience, Surgery and Trauma, Queen Mary University of London, London, UK.

Gavin Giovannoni (G)

Centre for Preventive Neurology, Wolfson Institute of Population Health, Queen Mary University of London, London, UK.
The Blizard Institute, Centre for Neuroscience, Surgery and Trauma, Queen Mary University of London, London, UK.
Clinical Board Medicine (Neuroscience), Barts Health NHS Trust, The Royal London Hospital, London, UK.

Klaus Schmierer (K)

The Blizard Institute, Centre for Neuroscience, Surgery and Trauma, Queen Mary University of London, London, UK.
Clinical Board Medicine (Neuroscience), Barts Health NHS Trust, The Royal London Hospital, London, UK.

Classifications MeSH